07:47 AM EDT, 08/27/2024 (MT Newswires) -- Boston Scientific ( BSX ) said Tuesday it secured CE mark approval for its Acurate Prime Aortic Valve System, a transcatheter aortic valve replacement designed to treat severe aortic stenosis across various risk levels.

The ACURATE Prime valve system, suitable for aortic annulus diameters of 20.5 mm to 29 mm, will be launched in Europe in the coming weeks, Boston Scientific ( BSX ) said.